Stock Region Penny Picks
🚀 Stocks That Are Making Moves! 🚀
🚀 Stocks That Are Making Moves! 🚀
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: Before we get into the good stuff, remember this is for informational and entertainment purposes only. We are not financial advisors, and this is not financial advice. Always do your own research before making any investment decisions. Trading involves risk.
Hope your week has been filled with green! It’s been a busy couple of days on the market, with some genuinely interesting moves happening. Let’s dive right into the tickers that have caught our eye.
Today’s Top Watchlist
$SPHL - Springview Holdings Ltd.
First up, we have an interesting play in the green energy space. SPHL announced a strategic partnership to bring solar solutions to residential housing in Singapore. This feels like a smart, forward-thinking move. Singapore is dense, wealthy, and pushing for sustainability. This could be a significant long-term growth catalyst if they execute well. Keep an eye on this one.
$BMNR - Bitmine Immersion Technologies
Okay, this one is wild. Bitmine announced a staggering $200 million investment in MrBeast’s company, Beast Industries. When you see a name like MrBeast involved, you have to pay attention. His reach is astronomical. This partnership could bring massive mainstream exposure to Bitmine. It’s an unconventional move, and that’s what makes it so intriguing.
$BNKK - Bonk, Inc.
The meme world meets the corporate world. Bonk, Inc. has welcomed TenX Protocols as a strategic partner right after its public debut. They also acquired a massive 220 billion BONK digital assets. This is a bold move to solidify their position in the digital asset space. It signals they’re serious about building an ecosystem, which could add some legitimacy and stability.
$GTBP - GT Biopharma
Shifting gears to biotech, GT Biopharma submitted an IND for its TriKE® cell engager, targeting solid tumors. Biotech news like this can be a major catalyst. An IND submission is a critical first step toward clinical trials. It’s a long road, but this is exactly the kind of milestone that gets a biotech stock on the radar.
$NITO - N2OFF (MitoCareX Bio)
This one is straight out of science fiction. N2OFF is highlighting its co-founder’s research on mitochondrial carriers in spaceflight stress conditions. Space-related biotech? Absolutely fascinating. While the direct commercial application might seem far off, this kind of pioneering research can attract significant attention and grants. It’s a story stock with a ton of intellectual horsepower behind it.
$AUID - authID
In the tech world, authID is integrating with ServiceNow to bring better identity verification to contact centers. This is a fantastic, practical application of their technology. ServiceNow is a massive platform, and integrating with them opens up a huge new sales channel for authID. It’s a “show me the money” type of partnership that we love to see.
$CJMB - Callan JMB
Here’s a deal with some serious numbers attached. Callan JMB signed an agreement with Attune that could be worth $50 to $75 million in total revenue. The agreement covers manufacturing, deployment, and commercialization. This isn’t just a plan; it’s a revenue-generating deal that could significantly impact their bottom line.
$ORIS - Orisun Acquisition Corp.
And finally, a little bit of good housekeeping news. ORIS has regained Nasdaq compliance. Why does this matter? It removes the immediate threat of being delisted, which provides a huge sigh of relief for investors and restores a baseline of stability for the stock. It’s a simple but incredibly important update.
That’s the rundown for today! What a mix of tech, biotech, and pure headline-grabbing news. Keep these on your radar, do your homework, and let’s see where they go from here.
Happy trading!
The Stock Region Team
Final Disclaimer: All investments carry risk. The information provided in this newsletter does not constitute investment advice, financial advice, trading advice, or any other sort of advice, and you should not treat any of the newsletter’s content as such. The Stock Region team provides information for educational and entertainment purposes only. Please conduct your own due diligence and consult your financial advisor before making any investment decisions.